Is the α/β for prostate tumors really low? In regard to Fowler et al., IJROBP 2001;50:1021–1031
- 1 April 2002
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 52 (5) , 1427-1428
- https://doi.org/10.1016/s0360-3016(01)02814-0
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- A theoretical investigation into the role of tumour radiosensitivity, clonogen repopulation, tumour shrinkage and radionuclide RBE in permanent brachytherapy implants of125I and103PdPhysics in Medicine & Biology, 2001
- Is α/β for prostate tumors really low?International Journal of Radiation Oncology*Biology*Physics, 2001
- Fractionation and protraction for radiotherapy of prostate carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1999
- The assessment of RBE effects using the concept of biologically effective doseInternational Journal of Radiation Oncology*Biology*Physics, 1999
- A calculation of the relative biological effectiveness of and brachytherapy sources using the concept of proximity functionMedical Physics, 1998
- Microdosimetric evaluation of relative biological effectiveness for 103Pd, 125I, 241Am, and 192Ir brachytherapy sourcesInternational Journal of Radiation Oncology*Biology*Physics, 1996
- The relative biological effectiveness of I-125 and Pd-103International Journal of Radiation Oncology*Biology*Physics, 1995
- A Statistical Theory of Cell Killing by Radiation of Varying Linear Energy TransferRadiation Research, 1994
- Which RBE for iodine 125 in clinical applications?Radiotherapy and Oncology, 1987
- The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapyThe British Journal of Radiology, 1985